Nanoscope Therapeutics is a clinical-stage biopharmaceutical company developing gene therapies to cure genetic diseases that cause vision impairment and blindness.
These diseases include Retinitis Pigmentosa, Dry Age-related Macular Degeneration (AMD), and Stargardt Disease. We are developing a proprietary platform technology, employing ambient light-sensitive Multi-Characteristic Opsins (MCO) that has potential to treat a broad range of genetic illnesses.
![NSCOPE_blue_DNA_ABOUT](https://32ib45.p3cdn1.secureserver.net/wp-content/uploads/2021/03/NSCOPE_blue_DNA_ABOUT.jpg?time=1722047012)